Cleared Traditional

K920633 - PESSARY FLEXIBLE SILICONE NICHOLS

K920633 is an FDA 510(k) clearance for PESSARY FLEXIBLE SILICONE NICHOLS, manufactured by Bioteque America, Inc.. The device is a Class 2 Obstetrics & Gynecology device with product code KXP cleared through the Traditional 510(k) pathway after a 1365-day FDA review.

K920633 · Bioteque America, Inc. · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1995
Decision
1365d
Days
Class 2
Risk

K920633 is an FDA 510(k) clearance for the PESSARY FLEXIBLE SILICONE NICHOLS. Classified as Stent, Vaginal (product code KXP), Class II - Special Controls.

Submitted by Bioteque America, Inc. (Langhorne, US). The FDA issued a Cleared decision on November 8, 1995 after a review of 1365 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.3900 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Obstetrics & Gynecology submissions.

View all Bioteque America, Inc. devices

FDA 510(k) Submission Details - K920633

510(k) Number K920633 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 12, 1992
Decision Date November 08, 1995
Days to Decision 1365 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
1205d slower than avg
Panel avg: 160d · This submission: 1365d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KXP Device Classification - Class 2, Special Controls

Product Code KXP Stent, Vaginal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.3900
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.